Manila Bulletin
Tagaytay City to start COVID-19 vaccination of minors
The Taguig City government started its COVID-19 vaccination program for minors aged 12 to 17 years old without comorbidities on November 2.
Vaccinations for minors without comorbidities are available at the Lakeshore Hall and Bonifacio High Street mega vaccination hubs.
Minors with comorbidities are exclusively vaccinated at Medical Center Taguig and may also book appointments at barangay health centers.
The vaccination drive for minors with comorbidities began on October 25 and 26 at specific hospitals.
Both Pfizer-BioNTech and Moderna vaccines are approved by the Philippine FDA for individuals aged 12 and above.
The Taguig City Vaccination Task Force adheres to the Department of Health's guidelines for vaccinating minors, categorized as Pediatric A3.
Registration is required via the TRACE app for appointments, and walk-ins are not permitted.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
Manila began its general COVID-19 vaccination for minors aged 12 to 17 on Wednesday, November 3, at six designated hospitals.
Read more →
The nationwide COVID-19 vaccination rollout for minors aged 12 to 17 is scheduled to begin in the National Capital Region on November 3, 2021, with nationwide implementation on November 5, 2021.
+2
Read more →
Over 20,000 minors in Manila have received their first dose of vaccine against COVID-19 as of November 6.
Read more →
Hundreds of minors aged 12 to 17 from Bacolod City and Negros Occidental received their first COVID-19 vaccine shots on October 29, 2021.
Read more →
Seventy minors aged 12 to 17 with comorbidities in Pangasinan received their COVID-19 vaccines at the Conrado F. Estrella Regional Medical and Trauma Center.
Read more →